Triglyceride landmark trials: Difference between revisions

	Triglyceride Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
Triglyceride Laboratory Test
High Triglyceride Epidemiology and Demographics Pathophysiology Causes Prognosis and Complications History and Symptoms Physical Examination
Low Triglyceride Epidemiology and Demographics Pathophysiology Causes Prognosis and Complications
Treatment
Lifestyle modification
Medical Therapy
Primary Prevention
Secondary Prevention
Landmark Trials
Future or Investigational Therapies
Case Studies
Case #1
Triglyceride landmark trials On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Triglyceride landmark trials All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Triglyceride landmark trials
CDC on Triglyceride landmark trials
Triglyceride landmark trials in the news
Blogs on Triglyceride landmark trials
Directions to Hospitals Treating Triglyceride
Risk calculators and risk factors for Triglyceride landmark trials

VisualWikitext

Latest revision as of 15:07, 15 September 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Landmark Trials

Niacin

AIM HIGH Study

Omega-3 Fatty Acids

References

Template:WH Template:WS

@@ Line 1: / Line 1: @@
-__NOTOC_
+__NOTOC__
 {{Triglyceride}}
 {{CMG}}
@@ Line 14: / Line 14: @@
 {{Lipopedia}}
+[[Category:Cardiology]]
+[[Category:Disease]]
 [[Category:Lipopedia]]
+[[Category:Lipids]]
+[[Category:Up-To-Date]]
+{{WH}}
 {{WS}}
-{{WI}}

v t e Lipopedia
Basic Science	Cholesterol • Triglyceride Lipoprotein metabolism and transport Lipoprotein: Chylomicron • Chylomicron remnant • HDL • IDL • LDL • Lipoprotein(a) • VLDL • Lipoprotein-X Apolipoprotein: APOA (1, 2, 4, 5) • APOB ( Apolipoprotein B-48, Apolipoprotein B-100) • APOC (1, 2, 3, 4) • APOD • APOE • APOH • APOJ • APOL • APOM • Apo(a) Lipoprotein receptor: LDL receptor • Soluble low density lipoprotein receptor-related protein (sLRP) • Apolipoprotein E Receptor 2 • Scavenger receptor • Scavenger receptor A • Scavenger receptor B • VLDL receptor Lipoprotein enzymes: Lipoprotein lipase • Lipoprotein-associated phospholipase A2 (Lp-PLA2) • Cholesterylester transfer protein ( Acetyl-CoA C-acyltransferase, Lecithin-cholesterol acyltransferase) • Microsomal triglyceride transfer protein • ABCA1 Genes: Low density lipoprotein receptor gene family • Microsomal triglyceride transfer protein • ABCA1
Lipoprotein Disorders	Lipoprotein disorders Primary lipoprotein disorders: Familial hyperchylomicronemia (Type I) • Familial hypercholesterolemia (Type IIA) • Familial combined hyperlipidemia (Type IIB) • Dysbetalipoproteinemia (Type III) • Primary hypertriglyceridemia (Type IV) • Mixed hyperlipoproteinemia (Type V) Secondary lipoprotein disorders
Abnormal Laboratory Lipid Profile	Low chylomicron • Low chylomicron remnant • Low HDL • Low IDL • Low LDL • Low lipoprotein(a) • Low VLDL High chylomicron • High chylomicron remnant • High HDL • High IDL • High LDL • High Lipoprotein(a) • High VLDL

Triglyceride landmark trials: Difference between revisions

Latest revision as of 15:07, 15 September 2013

Overview

Landmark Trials

Niacin

AIM HIGH Study

Omega-3 Fatty Acids

References

Navigation menu

Search